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Abstract 
Background: Substance use disorders (SUDs) constitute a major health problem and are associated with an exten‑
sive psychiatric comorbidity. Personality disorders (PDs) and SUDs commonly co‑occur. Comorbid PD is character‑
ized by more severe addiction problems and by an unfavorable clinical outcome. The present study investigated the 
prevalence of SUDs, PDs and common Axis I disorders in a sample of adolescent outpatients. We also investigated the 
association between PDs and SUDs, and how this association was influenced by adjustment for other Axis I disorders, 
age and gender.
Methods: The sample consisted of 153 adolescents, aged 14–17 years, who were referred to a non‑specialized 
mental health outpatient clinic with a defined catchment area. SUDs and other Axis I conditions were assessed 
using the mini international neuropsychiatric interview. PDs were assessed using the structured interview for DSM‑IV 
personality.
Results: 18.3 % of the adolescents screened positive for a SUD, with no significant gender difference. There was a 
highly significant association between number of PD symptoms and having one or more SUDs; this relationship was 
practically unchanged by adjustment for gender, age and presence of Axis I disorders. For boys, no significant associa‑
tions between SUDs and specific PDs, conduct disorder (CD) or attention deficit hyperactivity disorder (ADHD) were 
found. For girls, there were significant associations between SUD and BPD, negativistic PD, more than one PD, CD and 
ADHD.
Conclusions: We found no significant gender difference in the prevalence of SUD in a sample of adolescents referred 
to a general mental health outpatient clinic. The association between number of PD symptoms and having one or 
more SUDs was practically unchanged by adjustment for gender, age and presence of one or more Axis I disorders, 
which suggested that having an increased number of PD symptoms in itself may constitute a risk factor for develop‑
ing SUDs in adolescence. The association in girls between SUDs and PDs, CD and ADHD raises the question if ado‑
lescent girls suffering from these conditions may be especially at risk for developing SUDs. In clinical settings, they 
should therefore be monitored with particular diligence with regard to their use of psychoactive substances.
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Background
Personality disorders (PDs) are defined as enduring and 
maladaptive patterns of experiencing, coping, and relat-
ing to others. In DSM-IV, as well as DSM-5, PD catego-
ries may be applied to adolescents when the individual’s 
particular maladaptive personality traits appear to be 
pervasive, persistent, and unlikely to be limited to a par-
ticular developmental state or an episode of an Axis I dis-
order. With the exception of antisocial PD (ASPD), any 
PD can be diagnosed in a person under 18 years of age, 
as long as the diagnostic features have been present for at 
least 1 year [1, 2].
PDs are common conditions, with prevalences of about 
13 % in the general adult population, up to 40 % in adult 
outpatient samples, and up to 71 % in inpatient samples 
when diagnosed with comprehensive semi-structured 
interviews [3]. In adolescents, prevalences range from 
6 to 17  % in community samples, and in clinical sam-
ples from 41 to 64  % [4]. Pathological personality traits 
emerge at an early age and are related to health-risk 
behaviors in adolescence as well as young adulthood [5–
7], but PD diagnoses may be less stable than previously 
assumed [8]. Maladaptive personality trait constellations, 
however, seem to be more stable in their structure than 
PD diagnoses. They may change in severity or expression 
over time; still they often lead to persistent functional 
impairment and reduced quality of life, even if the diag-
nostic threshold for a specific PD is no longer reached [9, 
10].
Borderline PD is the single most studied PD, and is 
generally considered as the prototypical cluster B dis-
order. BPD may be more prevalent than previously rec-
ognized, with a lifetime prevalence of up to 2.7 % in the 
general adult population [11]. A large population study 
found BPD equally prevalent among men and women, 
and frequently associated with considerable mental and 
physical disability, especially among women [12]. There 
is an increasing awareness of developmental antecedents 
and adolescent presentation of BPD [13–15], with sev-
eral studies pointing out prognostic advantages of early 
identification and timely treatment of PDs [16, 17]. It has 
recently been shown that the diagnosis of BPD is as reli-
able and valid in adolescents as it is in adults, and that 
adolescents with BPD can benefit from early intervention 
[18].
Substance use disorders (SUDs) constitute a major 
health problem, with estimated prevalence rates of 
3.4  % for alcohol dependence and 0.3–1.8  % for can-
nabis dependence in the general European population 
[19]. It has generally been assumed that boys use more 
drugs and alcohol than girls. However, recent findings 
seem to contradict this long-held assumption; John-
son and colleagues found that male–female differences 
in adolescent marijuana use have decreased since 1999 
[20], and another study reports that the differences in 
drinking patterns of adolescent boys and girls narrowed 
between 2002 and 2012 [21]. Drug abuse is associated 
with an extensive psychiatric comorbidity and carries 
an increased risk of premature death, especially in male 
users of opiates or barbiturates [22]. Estimated lifetime 
prevalences of SUDs in adolescents and young adults 
range from 4.6 [23] to 17.7 % [24]. In adolescents, SUDs 
are of considerable importance in the etiology and prog-
nosis of psychiatric disorders such as mood disorders, 
conduct disorder (CD), attention-deficit hyperactivity 
disorder (ADHD), and anxiety disorders [25]. In adults, 
generalized anxiety disorder (GAD) and SUDs are highly 
comorbid, and GAD–SUD comorbidity is associated with 
a host of poor psychosocial outcomes, including higher 
rates of hospitalization, disability, functional impairment, 
and inferior GAD and SUD treatment outcomes [26].
Adolescents with SUDs tend to have higher rates of 
comorbid psychiatric disorders and are more likely to 
report a history of trauma and physical and/or sexual 
abuse than adolescents without a SUD [27, 28]. In addi-
tion, psychiatric disorders in adolescents often predate 
the SUD. Once the SUD develops, the psychiatric disor-
der may be further exacerbated [29] and associated with 
substantial functional impairment [30]. In older adoles-
cence and emerging adulthood, young drug users with 
comorbid affective disorders have greater mental health 
and substance use morbidity than those with substance 
use problems alone [31]. A study of adolescent SUD inpa-
tients found that 40.5 % of the participants fulfilled crite-
ria for at least one comorbid present Axis I disorder, with 
high prevalences of mood, anxiety, and somatoform dis-
orders. The 37 female participants showed a significantly 
higher risk for lifetime comorbid disorders; the gender 
difference was especially pronounced for anxiety and 
somatoform disorders [32].
ADHD has been shown to be a significant risk factor 
for developing SUDs [33]. It is frequently present in SUD 
populations, with prevalence estimates varying between 
14 and 23 %. In general, patients with this type of comor-
bidity represent a more severe subgroup of SUD patients 
with more additional comorbidity and a more disadvan-
tageous prognosis than SUD patients without ADHD 
[34]. It has been suggested that girls with ADHD might 
be at slightly higher risk than boys for substance abuse 
[35]. CD is a risk factor of similar magnitude as ADHD, 
and of equal importance in both genders [35].
PDs and SUDs commonly co-occur, with many stud-
ies finding a particularly frequent association between 
SUDs and BPD or ASPD [25, 36–38]. Comorbid PD 
seems to be more prevalent in drug use disorder (DUD) 
than in alcohol use disorder (AUD) [37]. Comorbid PD is 
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characterized by more severe addiction problems and by 
an unfavorable clinical outcome [39]. Prevalence rates of 
PDs in patients with SUD range from 24 to 90 %, depend-
ing on the sample characteristics and setting [11, 40–42]. 
A Norwegian study of first-admission SUD patients aged 
16 years and older, found that 46 % of the patients had at 
least one PD. In this sample, cluster C disorders were as 
prevalent as cluster B disorders; SUD patients with PDs 
were younger at the onset of their first SUD and at admis-
sion; they used more illicit drugs; had more anxiety disor-
ders; had more severe depressive symptoms; were more 
distressed and more impaired in their social functioning 
[37]. Comorbid SUD can be diagnosed in approximately 
every second patient suffering from a PD [36].
Some studies have reported gender differences in ado-
lescents and young adults; Foster and colleagues found 
AUD to be a more severe disorder in women than in 
men. Despite lower mean levels of overall risk exposure, 
women were characterized by higher levels of adoles-
cent risk factors and a greater magnitude of AUD conse-
quences. Furthermore, internalizing symptoms appeared 
to be a gender-specific risk factor for AUD in women 
[43]. Roberts and colleagues found a tendency in females 
with SUDs to have higher rates of comorbid disorders, 
as did older youths [30]. Thus, the question of possible 
gender differences in SUD prevalence, comorbidity and 
prognosis has not yet been fully answered.
Aims
The objective of the present study, performed on a clini-
cal sample of consecutively referred adolescent outpa-
tients, was to
1. Investigate the prevalences of alcohol and substance 
abuse and common Axis I disorders, including pos-
sible gender differences.
2. Investigate the association between PDs and alcohol 
and other substance abuse. We also wanted to assess 
the influence of adjusting for other Axis I disorders, 
age and gender on this association.
Methods
Participants
The present study used a sample of adolescents aged 
14–17  years who were referred to a mental health out-
patient clinic for children and adolescents in Oslo (The 
Nic Waal Institute, Lovisenberg Diakonale Hospital). The 
catchment area of the clinic comprises 25.000 children 
and adolescents from 0 to 17  years of age, and consists 
of four city districts with a population of mixed socio-
economic status, representing all social classes including 
immigrant workers and well-educated middle and upper 
class families. Study inclusion took place from February 
2005 to April 2007. All referred patients in the study’s age 
group were asked to participate. Exclusion criteria were 
the need for immediate hospitalization or other urgent 
therapeutic measures, clinically assessed mental retar-
dation, lack of fluency in the Norwegian language, and 
absence of the evaluator at the time of referral [44].
Measures
As in other comparable studies on the prevalence of Axis 
I and Axis II disorders in adolescents, well validated adult 
diagnostic tools have been used [45–48].
Axis I disorders
Axis I disorders, including SUDs, were assessed using a 
Norwegian translation of the mini international neu-
ropsychiatric interview version 5.0.0 (MINI) [49, 50]. The 
MINI has not been validated for adolescents, but has pre-
viously been used in studies on adolescents [51] and was 
chosen for its excellent feasibility [50].
In the assessment of ADHD a primary screening was 
first performed, using the six-item adult ADHD Self-
Report Scale Screener version 1.1 (ASRS Screener) in a 
Norwegian version [52]. The ASRS Screener is reliable 
and valid in adult clinical settings, with excellent speci-
ficity [53]. It has repeatedly been shown to be in strong 
concordance with clinician diagnoses [54]. The ASRS 
Screener has not been validated for use in adolescents, 
but the full 18-item ASRS symptom checklist, from 
which it is derived, has been found to be reliable and 
valid in adolescents [55].
If the primary screening with the ASRS Screener was 
positive, the Mini International Neuropsychiatric Inter-
view-PLUS (MINI-PLUS) section W (ADHD in children/
adolescents) was used as a diagnostic test instrument 
[50] for a final diagnosis of ADHD.
Personality disorders
The Structured Interview for DSM-IV (SIDP-IV) [56] in a 
Norwegian version was used to assess PDs. The SIDP-IV 
is a comprehensive semi-structured diagnostic interview 
for DSM-IV PD (Axis II) diagnoses, which has been used 
in numerous studies in different countries, including 
Norway [57–59]. The SIDP-IV has been extensively used 
in research on PDs in adolescence [51, 60, 61]. The SIDP-
IV covers 14 DSM-IV Axis II diagnoses as well as CD as 
a separate axis I disorder. The Axis II diagnoses comprise 
the ten standard DSM-IV PDs (paranoid, schizoid, schi-
zotypal, borderline, histrionic, narcissistic, antisocial, 
obsessive–compulsive, dependent, and avoidant PD), the 
three provisional DSM-IV PDs (self-defeating, depres-
sive, and negativistic PD), and mixed PD.
All questions address the typical or habitual behavior 
of the subjects during the last 5  years. Each diagnostic 
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criterion is rated on a four point scale: “0”  =  criterion 
not present; “1” = subthreshold level of the trait present; 
“2” = criterion being present for most of the last 5 years; 
and “3” =  criterion strongly present. Scores “2” and “3” 
indicate the presence of a criterion according to DSM-IV 
[56]. In the following text, we will be using the term “PD 
symptoms” when a diagnostic criterion meets a score of 
1, 2 or 3. “PD” is used when a sufficient number of diag-
nostic criteria for a specific DSM-IV diagnosis are ful-
filled, as measured with the SIDP-IV.
In accordance with diagnostic practice applied in other 
studies on PDs in adolescence, the DSM-IV age criterion 
for ASPD was waived [45]. Due to the participants’ age, 
we also waived the 5  year symptom duration criterion. 
Instead we used 2 years symptom duration as criterion. 
This is in accordance with the criterion used in previous 
studies assessing adolescent personality pathology [4, 45].
Procedures and assessment
All patients were assessed immediately upon referral by 
the first author, who was a male specialist in psychiatry 
and child and adolescent psychiatry, with 21  years of 
clinical experience. He was trained in evaluation with 
SIDP-IV by the second author, who was an experienced 
rater, who had previously evaluated patients and reported 
from comparable studies in adults [59, 62]. Twenty rat-
ings were discussed and found to be in accordance with 
the rating of the experienced evaluator. Axis I condi-
tions were also assessed by the first author, who had been 
trained by the translator of the Norwegian version of the 
MINI.
After completion of the initial assessment, the patients 
were assigned to further clinical evaluation and treat-
ment by clinicians other than the first author in the out-
patient clinic.
Statistical analysis
Descriptive statistics were calculated for the relevant 
mental health status variables and expressed in mean 
[with standard deviation (SD) in parentheses] and fre-
quency (percentages in parentheses) as appropriate. 
Prevalences of PDs, SUDs and other Axis I conditions 
with 95 % Blaker confidence intervals [63] were estimated 
for the total sample and for each gender separately, with 
testing for gender differences by exact Chi square tests. 
SUD was classified as none, one [either AUD or canna-
bis use disorder (CUD)] and two (both AUD and CUD). 
The association of SUD with number of PD symptoms, 
unadjusted and adjusted for gender, age and presence of 
Axis I disorders was investigated by proportional odds 
ordinal logistic regression. Differences in unadjusted and 
adjusted odds ratios were, if necessary, investigated by a 
bootstrap BCa 95 % confidence intervals based on 10,000 
bootstrap replicates [64], with a difference considered as 
significant if 0 was outside the interval. Data were ana-
lysed using the IBM SPSS version 20.0 software, with 
Blaker confidence intervals and bootstrapping using the 
R (The R Foundation for Statistical Computing, Vienna, 
Austria) packages BlakerCI and boot.
Ethical statement
The study was approved by the regional committee for 
medical research ethics for eastern Norway (REK: 11395) 
and by The Norwegian Data Inspectorate. Informed 
written consent was obtained from all patients, and for 
patients younger than 16 years consent was additionally 
obtained from their parents.
Results
In the study inclusion period a total of 264 adolescents 
(59.4 % female) were referred to The Nic Waal Institute. 
Sixty-three patients did not meet the inclusion crite-
ria; they were excluded due to inadequate fluency in 
the Norwegian language (N = 6, 9.5 %), mental retarda-
tion (N = 15, 23.8 %), need of immediate hospitalization 
(N = 19, 30.2 %), and absence of the evaluator at the time 
of referral (N  =  23, 36.5  %). This left 201 adolescents 
eligible for inclusion in the study. The attrition was 48 
(23.9  %); lack of consent from parents (N =  5, 10.4  %), 
referral retracted prior to interview (N = 6, 12.5 %), lack 
of consent from the adolescent (N = 7, 14.6 %), did not 
show up for appointment (N = 11, 22.9 %), and consent 
retracted during interview (N = 19, 39.6 %) [44].
A total of 153 adolescents (61.4  % girls, mean age 
16.0 years; SD = 1.1, range 14.1–18.0 years) were finally 
included in the study. There were no missing data in any 
items within the ASRS Screener, MINI, MINI-PLUS sec-
tion W, or SIDP-IV.
Of the adolescents, 18.3  % (N  =  28, 95  % CI 12.6–
25.3 %) were diagnosed with a SUD using the MINI, with 
no significant gender difference in prevalence (Table  1). 
Apart from alcohol, cannabis was the only drug in the 
sample that qualified for either an abuse or a depend-
ency diagnosis. When analysed separately for alcohol 
and cannabis problems in each gender, boys had slightly 
more alcohol-related problems, whereas girls had slightly 
more cannabis-related problems; the differences were 
not significant (alcohol; χ2 = 0.027, p = 1.000, cannabis 
χ2  =  0.055, p  =  1.000). The female/male ratio of SUDs 
was 1.16 (95 % CI = 0.49–2.72, p = 0.73).
Two thirds (63.4 %, N = 97) of the adolescents met the 
criteria for at least one Axis I disorder (68.1 %, N =  64 
girls; 56.0  %, N  =  33 boys). Anxiety disorders; simple 
phobias, GAD, panic disorder, agoraphobia, social pho-
bia and post-traumatic stress disorder (33.3  %, N =  51, 
95 % CI 26.0–41.1 %) and mood disorders; dysthymia and 
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major depressive episode (32.7 %, N = 50, 95 % CI 25.3–
40.5  %) were most frequent, followed by SUD (18.3  %, 
N = 28, 95 % CI 12.6–25.3 %), CD (17.6 %, N = 27, 95 % 
CI 12.2–24.4  %), obsessive–compulsive disorder (9,2  %, 
N  =  14, 95  % CI 5.3–14.8  %) and psychotic disorders 
(1.3  %, N  =  2, 95  % CI 0.2–4.6  %). There were signifi-
cant gender differences in anxiety (p = 0.022) and mood 
(p = 0.033) disorders (Table 1).
Of the adolescents, 21.6 % (N = 33) had at least one PD, 
7.2 % (N = 11) had more than one PD, and 4.6 % (N = 7) 
had both ADHD and a PD. The prevalence of PDs was 
generally higher in the referred girls. Girls showed sig-
nificant associations between SUD and BPD (p = 0.024), 
negativistic PD (p  =  0.035), more than one PD 
(p = 0.020) as well as between SUD and CD (p = 0.001) 
and ADHD (p < 0.001) (Table 2).
Figure 1 illustrates the association between PD symp-
toms and SUD and other frequent Axis I disorders. As 
can be seen, girls had more symptoms than boys in all 
reported Axis I conditions; the difference was signifi-
cant for anxiety disorders (p =  0.022) and mood disor-
ders (p = 0.033). Substance disorders (p = 0.831) and CD 
(p = 0.585) did not yield significant gender differences.
There was a significant positive association between the 
number of PD symptoms and SUD (OR per five points 
difference in the number of PD symptoms 1.16, 95 % CI 
1.06–1.26, p  =  0.001). The association was still signifi-
cant after adjustment for gender, age and presence of one 
or more Axis I disorders (OR 1.15, 95  % CI 1.04–1.27, 
p  =  0.005). There were no significant deviations from 
the proportional odds assumption in these analyses 
(p ≥  0.466). No bootstrap procedure for comparing the 
unadjusted and adjusted ORs was performed due to the 
almost total overlap between the confidence intervals.
Discussion
The present study investigated the prevalence of SUDs 
and common Axis I disorders in an unselected sample of 
adolescents. The participants were all referred to a non-
specialized mental health outpatient clinic with a defined 
catchment area. We also investigated the association 
between PD symptoms and SUDs, as well as how this 
relationship was influenced by adjustment for other Axis 
I disorders, age and gender.
Our finding of 18.3  % of the adolescents having AUD 
or CUD seems not to be incongruent with previous find-
ings, considering that studies of non-referred adolescents 
have found SUD prevalence rates of 4.6 % [23] to 17.7 % 
[24], and the prevalence rate in adolescent and young 
adult inpatients has been reported to be up to 54 % for 
DUD and 87 % for AUD when first admitted to hospital 
treatment [37]. As was to be expected, the participants in 
the present study had a higher prevalence of SUDs than 
has been found in studies of community samples and pri-
mary care patients but a lower prevalence than that seen 
in participants in studies of more severely ill patients.
An earlier study of adolescents has reported signifi-
cantly higher risk for lifetime comorbid disorders in 
Table 1 Prevalence of SUD, other Axis I disorders and personality disorders (N = 153)
SUD substance use disorders: alcohol and/or drug abuse or dependence. SUD is equivalent to AUD and/or CUD, since no other substances were used in our data; 
AUD alcohol use disorders: alcohol abuse or dependence; CUD Cannabis use disorders: Cannabis abuse or dependence; Anxiety anxiety disorders: simple phobias, 
generalized anxiety disorder, panic disorder, agoraphobia, social phobia and post-traumatic stress disorder; Mood mood disorders: dysthymia and major depressive 
episode; OCD obsessive–compulsive disorder; CD conduct disorder; ADHD attention deficit hyperactivity disorder
a Blaker 95 % confidence intervals
b p value from exact Chi square test








Without SUD 49 (83.1 %) (71.5–91.3 %) 76 (80.9 %) (71.5–88.1 %) 125 (81.7 %) (74.6–87.3 %) –
With SUD 10 (16.9 %) (8.7–28.5 %) 18 (19.1 %) (11.9–28.5 %) 28 (18.3 %) (12.6–25.3 %) 0.831
With AUD 7 (11.9 %) (5.38–22.5 %) 10 (10.6 %) (5.46–18.3 %) 17 (11.1 %) (6.73–17.1 %) 1.000
With CUD 7 (11.9 %) (5.38–22.5 %) 12 (12.8 %) (7.08–21.0 %) 19 (12.4 %) (7.93–18.5 %) 0.540
Anxiety 13 (22.0 %) (13.0–34.5 %) 38 (40.4 %) (30.7–50.7 %) 51 (33.3 %) (26.0–41.1 %) 0.022
Mood 13 (22.0 %) (13.0–34.5 %) 37 (39.4 %) (29.6–49.6) 50 (32.7 %) (25.3–40.5 %) 0.033
Psychosis 0 (0.0 %) (0.0–6.0 %) 2 (2.1 %) (0.4–7.1 %) 2 (1.3 %) (0.2–4.6 %) 0.523
OCD 4 (6.8 %) (2.3–16.4 %) 10 (10.6 %) (5.5–18.3 %) 14 (9.2 %) (5.3–14.8 %) 0.568
CD 12 (20.3 %) (11.3–32.8 %) 15 (16.0 %) (9.5–24.8 %) 27 (17.6 %) (12.2–24.4 %) 0.519
ADHD 9 (15.3 %) (7.9–26.8 %) 12 (12.8 %) (7.1–21.0 %) 21 (13.7 %) (8.9–20.1 %) 0.810
PD diagnosis 8 (13.6 %) (1.3–7.3 %) 25 (26.6 %) (6.0–24.4 %) 33 (21.6 %) (15.5–28.6 %) 0.070
No diagnosisc 23 (39.0 %) (26.8–52.2 %) 28 (29.8 %) (21.0–39.8 %) 51 (33.3 %) (26.0–41.1 %) 0.168
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women, with an especially pronounced gender difference 
for anxiety and somatoform disorders [32]. In the present 
study, however, significant gender differences in anxiety 
and mood disorders were found only in the adolescents 
that did not have SUDs.
It has been suggested that girls with ADHD might be 
at slightly higher risk than boys for substance abuse [35]. 
In accordance with this, the present study found signifi-
cantly more ADHD as well as CD in girls than in boys 
with SUDs.
Recent findings have contradicted the assumption that 
boys generally use more drugs and alcohol than girls [20, 
21]. Our findings of non-significant differences between 
genders in SUD prevalence are in accordance with this 
trend. Other recent studies have reported AUD to be a 
more severe disorder in adolescents and young adults, 
with higher levels of adolescent risk factors and a greater 
magnitude of AUD consequences in women [43], as well 
as a tendency in females with SUDs to have higher rates 
of comorbid disorders [30]. The cross-sectional nature of 
the present study makes it impossible to infer causal rela-
tionships, but our findings do support the assumption of 
a more extensive psychiatric comorbidity in female ado-
lescent SUD patients.
The main finding of the present study is a highly sig-
nificant association between number of PD symptoms 
and the presence of one or more SUDs (p  =  0.001), 
with almost totally overlapping confidence intervals 
after adjustment for gender, age and presence of one or 
more Axis I disorders (p = 0.005). This finding implies 
that having an increased number of PD symptoms in 
Table 2 Prevalence of specific personality disorders, conduct disorder, and ADHD in adolescents with SUD (N = 153)
SUD substance use disorders: alcohol and/or drug abuse or dependence
a p values from exact Chi square tests









Paranoid 0 0 – – 0 0 – –
Schizoid 0 1 0.183 1.000 0 0 – –
Schizotypal 0 0 – – 0 0 – –
Antisocial 1 1 1.606 0.313 1 2 4.519 0.093
Borderline 1 0 4.984 0.169 4 3 7.052 0.024
Histrionic 0 0 – – 2 3 1.483 0.243
Narcissistic 0 0 – – 0 1 0.239 1.000
Avoidant 0 3 0.645 0.638 1 5 0.026 1.000
Dependent 0 0 – – 0 1 0.239 1.000
Obsessive–compulsive 0 0 – – 0 6 1.518 0.350
Self‑defeating 0 0 – – 0 0 – –
Depressive 0 2 0.422 1.000 2 6 0.193 1.000
Negativistic 0 0 – – 2 0 8.628 0.035
At least one PD 1 7 0.130 1.000 7 18 1.723 0.237
More than one PD 1 0 4.984 0.169 5 5 6.880 0.020
Conduct disorder 4 8 2.873 0.189 8 7 13.472 0.001
ADHD 2 7 0.210 1.000 8 4 20.062 <0.001
Fig. 1 PD symptoms in adolescents with SUD and other Axis I 
disorders. PD Symptoms any PD criteria meeting a score of 1,2 or 
3 when measured with the SIDP‑IV; SUD substance use disorders; 
alcohol and/or drug abuse or dependence. Alcohol alcohol abuse 
or dependence; Cannabis Cannabis abuse or dependence; Anxiety 
anxiety disorders, simple phobias, generalized anxiety disorder, panic 
disorder, agoraphobia, social phobia and post‑traumatic stress disor‑
der; Mood mood disorders, dysthymia and major depressive episode; 
CD conduct disorder; ADHD attention deficit hyperactivity disorder. 
** p < 0.05
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itself is a unique risk factor for the later development 
of a SUD.
Strengths and limitations
The study was performed at a single general service men-
tal health outpatient clinic, receiving adolescents from a 
geographically defined urban area with a varied socio-
economic and ethnic population. Still, the results from 
the present study may not be generalizable to other out-
patient populations. The participants were included in a 
limited time span, and we cannot exclude the possibility 
of prevalence fluctuations over time.
The attrition (23.9 %, N = 48) and the relatively small 
sample size also constitute limitations. In particular, the 
sample size limits the degrees of freedom available, so 
that analysis of single PDs in some cases may be statisti-
cally underpowered. Therefore, we have mainly focused 
on the total number of PD symptoms rather than on spe-
cific PDs. This might constitute a limitation. However, in 
light of current epidemiological knowledge about PDs, 
the differentiation between having or not having a PD 
is clearly more relevant than the differentiation between 
specific PDs. It should also be pointed out that specific 
PD diagnoses merely reflect the presence of an arbitrarily 
stipulated number of PD symptoms; there is no indica-
tion whatsoever of the existence of categorical breaking 
points at a given number of PD symptoms. On the con-
trary, recent literature supports the notion of PDs as 
dimensional entities with arbitrarily defined diagnostic 
cut-off points deciding whether or not a patient is above 
the diagnostic threshold for a specific disorder [4, 65].
The gender distribution of our sample was close to 
identical to the gender distribution of all referred adoles-
cents in the study inclusion period, and reflects the fact 
that in adolescence, as opposed to middle and late child-
hood, more girls than boys are referred to Norwegian 
mental health outpatient clinics.
Each patient was diagnosed individually with well-doc-
umented and semi-structured test instruments by a sin-
gle, experienced clinician and rater. Due to the fact that 
just one person performed all assessment work, there 
was no missing data. The evaluator was trained in rating 
with SIDP-IV and MINI by experienced evaluators and 
researchers on PD and Axis I diagnoses. Notwithstand-
ing, the use of a single evaluator constitutes a possible 
limitation; it may have strengthened the internal validity, 
but might have been a threat to the external validity of 
the diagnoses.
Conclusions
The present study comprised 153 adolescents referred 
to a non-specialized mental health outpatient clinic. Of 
these adolescents, 18.3  % screened positive for AUD or 
CUD, with no significant gender difference in preva-
lence. The female/male ratio of SUDs was 1.13 (95  % 
CI = 1.10–1.17). More than two-thirds of the adolescents 
met the criteria for at least one Axis I disorder, with sig-
nificant gender differences in anxiety (p  =  0.022) and 
mood (p = 0.033) disorders; 21.6 % of the patients had at 
least one PD and 7.2 % had more than one PD. The prev-
alence of PDs was generally higher in the referred girls. 
For boys, no significant associations between SUDs and 
specific PDs or Axis I disorders could be ascertained. For 
girls, there were significant associations between SUD 
and BPD, negativistic PD, more than one PD, CD and 
ADHD.
There was a highly significant association between 
number of PD symptoms and the presence of one or more 
SUDs. This association was practically unchanged when 
adjusted for gender, age and having one or more Axis I 
disorders, suggesting that having an increased number of 
PD symptoms in itself may constitute a unique risk factor 
for developing SUDs in adolescence. These findings are 
in accordance with earlier reports of increased co-occur-
rence of PDs and SUDs in adolescence [36–38].
However, the girls in the study were overall more 
severely ill than the boys; girls with SUDs differed even 
more so, with significant associations between SUDs 
and BPD (p = 0.024), negativistic PD (p = 0.035), more 
than one PD (p =  0.020), as well as between SUDs and 
CD (p  =  0.001) and ADHD (p  <  0.001). This indicates 
that adolescent girls suffering from these disorders may 
be especially at risk for developing SUDs. In clinical prac-
tice, it might therefore be suggested that girls presenting 
with BPD, negativistic PD, more than one PD, ADHD, or 
CD should be monitored with particular diligence with 
regard to their use of psychoactive substances.
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